Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/30223
Title: Change in hepatitis C virus genotype in hemodialysis patients after end-of-treatment response to interferon monotherapy-relapse or re-infection?
Authors: Arrais, Teresa Cristina de Oliveira Maia [UNIFESP]
Van Dooren, Sonia
Vandamme, Anne-Mieke
Brechot, Christian
Rimlinger, Francois
Silva, Antonio Eduardo Benedito [UNIFESP]
Perez, Renata de Mello [UNIFESP]
Ferraz, Maria Lucia Cardoso Gomes [UNIFESP]
Thiers, Valerie
Erasmus MC
Universidade Federal de São Paulo (UNIFESP)
Katholieke Univ Leuven
Inst Pasteur
INSERM
Univ Paris Sud
Keywords: HCV
hemodialysis
nosocomial transmission
genotype
NS5B region
Issue Date: 1-Jan-2008
Publisher: Wiley-Blackwell
Citation: Journal of Medical Virology. Hoboken: Wiley-liss, v. 80, n. 1, p. 80-86, 2008.
Abstract: Hepatitis C virus (HCV) infection remains common among hemodialysis patients and its occurrence is related mainly to nosocomial spread. Although dialysis patients with HCV infection respond well to interferon-based therapy, relapse is frequent. This study aimed at a selected group of hemodialysis patients infected with HCV infection undergoing interferon therapy who achieved end-of-treatment virological response but became HCV-RNA positive again 6 months after end-of-treatment. It was evaluated whether de novo HCV-RNA positivity in these non-sustained responders occurred due to lack of clearance of HCV after the initial response to interferon-alpha (relapse) or due to re-infection with a new strain (re-infection). Genotyping by Inno-LiPA and by phylogenetic tree analysis using partial HCV-NS5B sequences at two evaluation points: pre-treatment (TO) and 6 months after end-of-treatment (T0). Non-sustained responders (n = 15) carried subtypes la (8 patients), 1b (4 patients), 3a (2 patients), and 4a (11 patient) before treatment. Identical subtypes were detected in 10 patients at T18. Five patients changed genotypes at T18, suggesting nosocomial re-infection. This study emphasizes the importance of epidemiologic measures to control the re-exposure of hemodialysis patients treated previously for HCV infection.
URI: http://repositorio.unifesp.br/handle/11600/30223
ISSN: 0146-6615
Other Identifiers: http://dx.doi.org/10.1002/jmv.21050
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.